Medroxyprogesterone

Category
hormone
Half-Life (t½)
PO: 50h · IM: 50h
Formula
C22H32O3
Molecular Weight
386.52 g/mol
PubChem CID
10631
Aliases
Provera, Depo-Provera, MPA, medroxyprogesterone acetate

Pharmacological Mechanism

Synthetic progestin (17α-hydroxyprogesterone derivative). Agonizes the progesterone receptor; suppresses pituitary LH/FSH to inhibit ovulation, thickens cervical mucus, transforms endometrium. Oral (HRT/amenorrhea/oncology) + IM depot (q3-month contraception).

Half-Life & Elimination Curve (PO: 50h · IM: 50h)

100%50%25%12.5%0%0h0×t½50h1×t½4.2d2×t½6.3d3×t½8.3d4×t½10.4d5×t½0×t½ (0h): 100% remaining (~4.38 µg/L)1×t½ (50h): 50% remaining (~2.19 µg/L)2×t½ (4.2d): 25% remaining (~1.09 µg/L)3×t½ (6.3d): 12.5% remaining (~0.547 µg/L)4×t½ (8.3d): 6.3% remaining (~0.274 µg/L)5×t½ (10.4d): 3.1% remaining (~0.137 µg/L)
Plasma (PO)t½ Decay (50h)
  • 0×t½0h100% (4.38 µg/L)
  • 1×t½50h50% (2.19 µg/L)
  • 2×t½4.2d25% (1.09 µg/L)
  • 3×t½6.3d12.5% (0.547 µg/L)
  • 4×t½8.3d6.3% (0.274 µg/L)
  • 5×t½10.4d3.1% (0.137 µg/L)
Elimination t½50h (PO)
Rate Constant (ke)0.0139 h⁻¹
Time to Peak (Tmax)2h
Est. Peak (Cmax)4.38 µg/L
Clearance (CL)13.9 L/h
97% Washout (5×t½)10.4d

Dosing Guidelines

Pharmacokinetic Parameters

Target Organ Systems

Chemical Structure & Identifiers

References